X-LINKED CHRONIC GRANULOMATOUS DISEASE
Clinical trials for X-LINKED CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new X-LINKED CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for X-LINKED CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene fix trial aims to tame rare immune disease
Disease control ENROLLING_BY_INVITATIONThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a genetic condition that weakens the immune system and leads to severe infections. Researchers take the patient's own stem cells, add a working copy of the faulty gene, and return the …
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Gene therapy hope for rare immune disease fails to launch
Disease control TerminatedThis trial aimed to test a gene therapy for X-linked chronic granulomatous disease, a condition where the immune system cannot fight certain infections. The treatment involved taking the patient's own stem cells, adding a working copy of the defective gene, and returning them to …
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Helixmith Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC